Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ·Healthcare·Biotechnology
$3.06
+3.73%
Mkt Cap $1.65M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$7.00
Range $6.00 – $8.00
Implied Upside
+128.8%
Consensus $7.00 vs current $3.06
NASDAQ·Healthcare·Biotechnology
$3.06
+3.73%
Mkt Cap $1.65M
No recent rating data.
Price Target (2 analysts)
$7.00
Range $6.00 – $8.00
+128.8%
Consensus $7.00 vs current $3.06